Abstract
MANY metabolic diseases affecting the central nervous system are refractory to treatment because the blood–brain barrier restricts entry of therapeutic molecules. It may be possible to deliver therapeutic gene products directly to the brain by transplantation of neural progenitor cells, which can integrate into the murine central nervous system in a cytoarchitecturally appropriate manner1–7. We tested this approach in mucopolysaccharidosis VII (Sly disease), a lysosomal storage disorder of humans, dogs and mice caused by an inherited deficiency of β-glucuronidase8–10 . Lysosomal accumulation of glycosaminoglycans occurs in the brain and other tissues, causing a fatal progressive degenerative disorder, including mental retardation11. Treatments are designed to provide a source of normal enzyme for uptake by diseased cells12–20. We report here that by transplanting β-glucuronidase-expressing neural progenitors into the cerebral ventricles of newborn mice, donor cells engrafted throughout the neuraxis. At maturity, donor-derived cells were present as normal constituents of diverse brain regions. β-Glucu-ronidase activity was expressed along the entire neuraxis, resulting in widespread correction of lysosomal storage in neurons and glia in affected mice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Snyder, E. Y. et al. Cell 68, 33–51 (1992).
Snyder, E. Y. Semin. Perinatol. 16, 106–121 (1992).
Snyder, E. Y., Yandava, B. D., Pan, Z-H., Yoon, C. & Macklis, J. D. Soc. Neurosci. Abstrs. 19, 613 (1993).
Macklis, J. D., Yoon, C. H. & Snyder, E. Y. Expl Neurol. 129, 9 (1994).
Renfranz, P. J., Cunningham, M. G. & McKay, R. D. G. Cell 66, 713–719 (1991).
Groves, A. K. et al. Nature 362, 453–455 (1993).
Onnifer, S. M., Whittemore, S. R. & Holets, V. R. Expl Neurol. 122, 130–142 (1993).
Sly, W. S., Quinton, B. A., McAlister, W. H. & Rimoin, D. L. J. Pediatr. 82, 249–257 (1973).
Haskins, M. E., Desnick, R. J., DiFerrante, N., Jezyk, P. F. & Patterson, D. F. Pediatr. Res. 18, 980–984 (1984).
Birkenmeier, E. H. et al. J. clin. Invest. 83, 1258–1266 (1989).
Neufeld, E. F. & Muenzer, J. in The Metabolic Basis of Inherited Disease 7th edn (eds Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D.) 2465–2494 (McGraw Hill, New York, 1995).
Haskins, M. E. et al. in Treatment of Genetic Diseases (ed. Desnick, R. J.) 183–202 (Churchill Livingstone, New York, 1991).
Birkenmeier, E. H. et al. Blood 78, 3081–3092 (1991).
Wolfe, J. H. et al. Nature 360, 749–753 (1992).
Wolfe, J. H., Deshmane, S. L. & Fraser, N. W. Nature Genet. 1, 379–384 (1992).
Sands, M. S. et al. Lab. Invest. 68, 676–686 (1993).
Moullier, P., Bohl, D., Heard, J.-M. & Danos, O. Nature Genet. 4, 154–159 (1993).
Marechal, V., Naffakh, N., Danos, O. & Heard, J.-M. Blood 82, 1358–1365 (1993).
Vogler, C. et al. Pediat. Res. 34, 837–840 (1993).
Sands, M. S. et al. J. clin. Invest. 93, 2324–2331 (1994).
Ryder, E. F., Snyder, E. Y. & Cepko, C. L. J. Neurobiol. 21, 356–375 (1990).
Kitchens, D. L., Snyder, E. Y. & Gottlieb, D. I. J. Neurobiol. 25, 797–807 (1994).
Altman, J. J. comp. Neurol. 137, 433–458 (1969).
Vogler, C. et al. Am. J. Path. 136, 207–217 (1990).
Wolfe, J. H. et al. Proc. natn. Acad. Sci. U.S.A. 87, 2877–2881 (1990).
Sands, M. S. & Birkenmeier, E. H. Proc. natn. Acad. Sci. U.S.A. 90, 6567–6571 (1993).
Kyle, J. W. et al. Proc natn. Acad. Sci. U.S.A. 87, 3914–3918 (1990).
Wolfe, J. H. et al. Gene Ther. 2, 70–78 (1995).
Taylor, R. M. & Wolfe, J. H. Expl Cell Res. 214, 606–613 (1994).
Christie, D. et al. Arch. Dis. Child 70, 275–280 (1994).
Suhr, S. & Gage, F. H. Arch. Neurol. 50, 1252–1268 (1993).
Breakefield, X. O. Nature Genet. 3, 187–189 (1993).
Fisher, L. J. & Gage, F. H. FASEB J. 8, 489–496 (1994).
Anton, R. et al. Expl Neurol. 127, 207–218 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Snyder, E., Taylor, R. & Wolfe, J. Neural progenitor cell engraftment corrects lysosomal storage throughout the MRS VII mouse brain. Nature 374, 367–370 (1995). https://doi.org/10.1038/374367a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/374367a0
This article is cited by
-
Umbilical mesenchymal stem cell-derived extracellular vesicles as enzyme delivery vehicle to treat Morquio A fibroblasts
Stem Cell Research & Therapy (2021)
-
Mifepristone-inducible transgene expression in neural progenitor cells in vitro and in vivo
Gene Therapy (2016)
-
von Willebrand factor contributes to poor outcome in a mouse model of intracerebral haemorrhage
Scientific Reports (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.